← All Oragenics INC filings

Oragenics INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

AMEX
OGEN
Oragenics INC
DEFA14A: Oragenics Clarifies Broker Voting Rules for 2024 Annual Meeting
Oragenics issues a supplement to its proxy statement clarifying the classification of proposals as routine or non-routine for broker voting purposes at the upcoming 2024 Annual Meeting of Stockholders.
AMEX
OGEN
Oragenics INC
DEF: Oragenics Seeks Shareholder Approval for Reverse Stock Split, Share Increase, and Incentive Plan Amendment
Oragenics, Inc. is asking shareholders to vote on proposals including a reverse stock split, an increase in authorized shares, and an amendment to the company's equity incentive plan at its upcoming annual meeting.
AMEX
OGEN
Oragenics INC
DEFA14A: Oragenics, Inc. Files Definitive Proxy Statement
Oragenics, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
AMEX
OGEN
Oragenics INC
DEF 14A: Oragenics Seeks Shareholder Approval for Director Elections, Executive Pay, and Equity Incentive Plan Amendment
Oragenics, Inc. is holding its 2023 Annual Meeting of Shareholders on December 11, 2024, to vote on key proposals including the election of directors, executive compensation, and an amendment to the company's equity incentive plan.